Nearly half the voting members of a Department of Health and Human Services linkurl:stem cell; advisory council have financial conflicts of interest despite the committee's pledge to limit these types of conflicts, according to a linkurl:survey; conducted by a science watchdog group. The Center for Science in the Public Interest polled the 25 voting members of HHS's linkurl:Advisory Council on Blood Stem Cell Transplantation; (ACBSCT) and found that 11 reported having financial ties to stem cell and linkurl:umbilical cord blood; banking companies, drug makers, and the linkurl:transplantation; industry. For example, linkurl:Frederick Appelbaum,; who is the head of medical oncology at the University of Washington, has relationships with Merck, Bristol-Myers Squibb, Wyeth, and Genzyme. Another council member, linkurl:Richard Champlin,; is the chairman of the University of Texas in Houston's Stem Cell Transplantation and Cellular Therapy Department, but also serves on the medical advisory board of linkurl:Stemcyte,; an international company that runs...

Interested in reading more?

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?